JP2021534121A5 - - Google Patents
Info
- Publication number
- JP2021534121A5 JP2021534121A5 JP2021506746A JP2021506746A JP2021534121A5 JP 2021534121 A5 JP2021534121 A5 JP 2021534121A5 JP 2021506746 A JP2021506746 A JP 2021506746A JP 2021506746 A JP2021506746 A JP 2021506746A JP 2021534121 A5 JP2021534121 A5 JP 2021534121A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- sequence shown
- amino acid
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000815A JP7728035B2 (ja) | 2018-08-10 | 2024-01-05 | 抗体による癌治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1813137.5A GB201813137D0 (en) | 2018-08-10 | 2018-08-10 | Cancer treatment with an antibody |
| GB1813137.5 | 2018-08-10 | ||
| PCT/EP2019/071627 WO2020030827A1 (en) | 2018-08-10 | 2019-08-12 | Cancer treatment with an antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000815A Division JP7728035B2 (ja) | 2018-08-10 | 2024-01-05 | 抗体による癌治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534121A JP2021534121A (ja) | 2021-12-09 |
| JP2021534121A5 true JP2021534121A5 (cg-RX-API-DMAC7.html) | 2022-08-18 |
| JP7428696B2 JP7428696B2 (ja) | 2024-02-06 |
Family
ID=63667034
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506746A Active JP7428696B2 (ja) | 2018-08-10 | 2019-08-12 | 抗体による癌治療 |
| JP2024000815A Active JP7728035B2 (ja) | 2018-08-10 | 2024-01-05 | 抗体による癌治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000815A Active JP7728035B2 (ja) | 2018-08-10 | 2024-01-05 | 抗体による癌治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11858982B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3833404A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7428696B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102974656B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112770786B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019319092B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021002435A2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201813137D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL280421B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021001604A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202014437A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020030827A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023089150A1 (en) | 2021-11-18 | 2023-05-25 | Medannex Ltd. | Combination therapy for cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2219299A1 (en) | 1997-10-24 | 1999-04-24 | Elias Georges | P-40, a new member of the multidrug resistance gene family |
| WO2004055519A2 (en) | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Specific markers for pancreatic cancer |
| WO2005027965A1 (en) | 2003-09-24 | 2005-03-31 | Peter Krammer | Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| CA2572451C (en) | 2004-06-02 | 2016-05-10 | Sidney Kimmel Cancer Center | Annexin a1 based vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| CN100571785C (zh) * | 2006-09-06 | 2009-12-23 | 中国医学科学院北京协和医院 | Annexin A3与癌症的铂类化疗药物耐药性的相关性 |
| GB0822011D0 (en) | 2008-12-02 | 2009-01-07 | Queen Mary & Westfield College | Treatment |
| EP2580241B1 (en) * | 2010-06-09 | 2020-11-04 | Queen Mary & Westfield College, University of London | Annexin 1 antibody |
| CN102898527B (zh) | 2011-07-25 | 2016-12-21 | 三星电子株式会社 | 融合蛋白、药物组合物及预防或治疗癌症的方法 |
| GB201121564D0 (en) | 2011-12-14 | 2012-01-25 | Queen Mary & Westfield College | Use of antibody |
| KR20150029457A (ko) * | 2013-09-10 | 2015-03-18 | 삼성전자주식회사 | 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도 |
| WO2015039175A1 (en) | 2013-09-18 | 2015-03-26 | Adelaide Research & Innovation Pty Ltd | Autoantibody biomarkers of ovarian cancer |
| CN104277102B (zh) * | 2014-06-27 | 2017-04-12 | 李光辉 | 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用 |
| GB201702091D0 (en) * | 2017-02-08 | 2017-03-22 | Medannex Ltd | Specific binding molecules |
| WO2019222618A1 (en) | 2018-05-17 | 2019-11-21 | The Trustees Of Columbia University In The City Of New York | Methods for treating, preventing and detecting the prognosis of colorectal cancer |
| JP2021533163A (ja) | 2018-08-07 | 2021-12-02 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | アネキシンａ１を介した心血管石灰化の阻害に関する方法および組成物 |
| WO2020112129A1 (en) | 2018-11-30 | 2020-06-04 | Prism | Proteogenomics Research Institute For Systems Medicine | Enhanced targeted delivery of therapeutic agents |
-
2018
- 2018-08-10 GB GBGB1813137.5A patent/GB201813137D0/en not_active Ceased
-
2019
- 2019-08-12 WO PCT/EP2019/071627 patent/WO2020030827A1/en not_active Ceased
- 2019-08-12 JP JP2021506746A patent/JP7428696B2/ja active Active
- 2019-08-12 CN CN201980064004.7A patent/CN112770786B/zh active Active
- 2019-08-12 TW TW108128652A patent/TW202014437A/zh unknown
- 2019-08-12 MX MX2021001604A patent/MX2021001604A/es unknown
- 2019-08-12 AU AU2019319092A patent/AU2019319092B2/en active Active
- 2019-08-12 EP EP19753344.1A patent/EP3833404A1/en active Pending
- 2019-08-12 IL IL280421A patent/IL280421B2/en unknown
- 2019-08-12 KR KR1020217007105A patent/KR102974656B1/ko active Active
- 2019-08-12 BR BR112021002435-2A patent/BR112021002435A2/pt unknown
- 2019-08-12 US US17/266,883 patent/US11858982B2/en active Active
-
2024
- 2024-01-05 JP JP2024000815A patent/JP7728035B2/ja active Active